We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Certara

News List

Certara and DMTC announce research collaboration to study preventative use of chloroquine in health pharmaceutical-business-review
May 12, 2020
Certara, the global leader in model-informed drug development, and DMTC (formerly the Defence Materials Technology Centre) Ltd, which works to enhance Australia’s defense and medical countermeasure capabilities, have entered into a research collaboration.
Certara Launches Hasharc Healthcare DApp with Hedera DLT biospectrumasia
September 20, 2019
Certara has been a Hedera user and partner since its infancy. “
Certara launches V8.2 of Phoenix PK/PD & simulation software for drug development biospectrumasia
September 16, 2019
Aligned with newly issued FDA Draft Guidance, Phoenix supports electronic data, methods and results audit, traceability and communication requirements
Certara Launches Industry-First Quantitative Systems Pharmacology (QSP) Consortium on Immuno-oncolog biospace
March 14, 2018
Certara®, the global leader in model-informed drug development and regulatory science, today announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium.